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RESEARCH ARTICLE
Fgf10 and Sox9 are essential for the establishment of distal
progenitor cells during mouse salivary gland development
Lemonia Chatzeli1, Marcia Gaete1,2 and Abigail S. Tucker1,*
ABSTRACT
Salivary glands are formed by branching morphogenesis with
epithelial progenitors forming a network of ducts and acini
(secretory cells). During this process, epithelial progenitors
specialise into distal (tips of the gland) and proximal (the stalk
region) identities that produce the acini and higher order ducts,
respectively. Little is known about the factors that regulate progenitor
expansion and specialisation in the different parts of the gland. Here,
we show that Sox9 is involved in establishing the identity of the distal
compartment before the initiation of branching morphogenesis. Sox9
is expressed throughout the gland at the initiation stage before
becoming restricted to the distal epithelium from the bud stage and
throughout branching morphogenesis. Deletion of Sox9 in the
epithelium results in loss of the distal epithelial progenitors, a
reduction in proliferation and a subsequent failure in branching. We
demonstrate thatSox9 is positively regulated bymesenchymal Fgf10,
a process that requires active Erk signalling. These results provide
new insights into the factors required for the expansion of salivary
gland epithelial progenitors, which can be useful for organ
regeneration therapy.
KEY WORDS: Branching morphogenesis, Epithelial progenitors,
Sox9, Fgf signalling, Salivary glands
INTRODUCTION
To develop therapeutic strategies for organ regeneration, we first
need to understand how progenitor cells contribute to organ
formation. During development, organs such as lungs, lacrimal
glands, pancreas and salivary glands undergo branching
morphogenesis, a process that efficiently increases the surface
area with a minimum increase of volume. Common to all branching
epithelium, the embryonic salivary gland epithelium starts as a
placode (also known as the prebud), which then elongates leading to
the formation of a stalk attached to the bud (also known as the initial
bud). The epithelium then undergoes sequential rounds of epithelial
budding, clefting and epithelial outgrowth creating a highly
branched network divided into ducts and endbuds (Affolter et al.,
2003), these endbuds forming the secretory acini of the adult gland.
Branching morphogenesis in many organs has been shown to
require constant interactions between the epithelium, mesenchyme,
blood vessels and nerves (Knosp et al., 2012). Salivary glands have
long been used as a model to study branching morphogenesis
because of their ease of ex vivo manipulation (Tucker, 2007).
Among the three major types – submandibular (SMG) secreting
seromucous saliva, sublingual (SL) secreting mucous saliva, and
parotid (PG) secreting serous saliva – the SMG is the most
commonly studied.
As the epithelium initiates and undergoes branching it becomes
specialised into distinct epithelial compartments. In salivary glands,
the earliest stage reported for this specialisation is after the initiation
of branching at the pseudoglandular stage [embryonic day (E) 13.5]
(Lombaert et al., 2011, 2013; Knox et al., 2010; Arnold et al., 2011).
Based on the position of cells within the developing gland and the
expression of progenitor markers, the epithelium is divided into
proximal and distal progenitors. In salivary glands, the proximal
progenitors, the cells located closer to the oral epithelium at the stalk
region, express markers such as cytokeratin 5 (K5; also known as
keratin 5, Krt5) and Sox2 [SRY (sex-determining region Y)-box 2]
(Lombaert et al., 2011; Knox et al., 2010; Arnold et al., 2011). The
distal progenitors, located at the end of the gland, express
cytokeratin 14 (K14; also known as keratin 14, Krt14), Kit and
Sox10 (Lombaert et al., 2013). Myb is also expressed by the distal
epithelial progenitors, as shown at E17.5 when terminal
differentiation starts to occur (Matsumoto et al., 2016). The
location of epithelial progenitors at specific time points during
development has been suggested to determine their progeny. When
epithelial rudiments of E13.5 SMGs were cultured ex vivowith Fgf7
and Fgf1, the distal epithelial progenitors labelled after a day in
culture contributed to the formation of acini (secretory cells
producing saliva) and secondary- and tertiary-branched ducts.
However, when labelled after 3 days in culture at a stage when pro-
acinar differentiation had already initiated, their lineage was
restricted to the acinar compartments. The more proximal
progenitors, on the other hand, could only contribute to the
formation of higher order branched ducts (Matsumoto et al., 2016).
Lumen formation in the ducts is marked by F-actin deposition
whereas acinar differentiation is marked by the expression of Mist1
(bHLHa15) (Walker et al., 2008; Aure et al., 2015). Interestingly,
distal epithelial progenitors have been shown to be more
proliferative than proximal progenitors (Steinberg et al., 2005;
Matsumoto et al., 2016).
Although there is increasing information on the factors that
regulate salivary gland branching morphogenesis, little is known
about the signals that control the expansion of the different epithelial
progenitors, or whether the distal epithelial progenitors alone are
required for branching morphogenesis. Acetylcholine signalling
through the parasympathetic ganglion was shown to promote the
expansion of K5+ cells and their differentiation to the ductal K19
(Krt19)+ lineage by a process that required epidermal growth factorReceived 30 October 2016; Accepted 10 May 2017
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receptor (EGFR) signalling (Knox et al., 2010). On the other hand,
epithelial Wnt and Fgf receptors in combination with Kit signalling
were shown to promote the expansion of the distal Sox10+K14+
population (Lombaert et al., 2013; Matsumoto et al., 2016). Key
pathway components for Fgf signalling in developing salivary
glands are Fgf10 and its receptor Fgfr2, as mutations in either of
these two genes lead to an arrest of salivary gland development at
the placode stage (Jaskoll et al., 2005). Fgf10 is expressed in the
neural crest-derived mesenchyme that surrounds the gland, with
conditional knockout of Fgf10 in the neural crest mimicking the null
phenotype (Teshima et al., 2016a), whereas Fgfr2 is expressed in
the gland epithelium (Jaskoll et al., 2002). Similar to salivary
glands, other branching organs were also arrested after knockout of
Fgf10, including the lung and lacrimal glands, and the pancreas was
hypoplastic (Ohuchi et al., 2000).
In the lungs, lacrimal glands and pancreas, Fgfr2 signalling has
been shown to regulate the expression of Sox9, which appears to act
as a distal epithelial marker (Abler et al., 2009; Chang et al., 2013;
Chen et al., 2014; Seymour et al., 2012). Sox9 is a transcription
factor that belongs to the highly conserved SOX family (subgroup
E) characterised by the presence of the high mobility group DNA-
binding domain of SRY (Pritchett et al., 2011). Initially Sox9 was
identified as a gene linked to campomelic dysplasia, a syndrome that
causes male-to-female sex reversal and skeletal defects (Wagner
et al., 1994). Apart from its importance in gonadal formation and
chondrogenesis, Sox9 is expressed in the epithelium of many
developing branching organs, including lacrimal glands, lungs,
pancreas and kidneys. Its requirement for their development varies
as conditional Sox9 inactivation results either in complete agenesis,
as in the case of the lacrimal glands (Chen et al., 2014), or in
hypoplasticity, as in the case of the lungs and pancreas (Chang et al.,
2013; Rockich et al., 2013; Seymour et al., 2007). Kidneys also rely
on Sox9 expression for their development; however, the severity of
the phenotype is variable and ranges from agenesis to hypoplasia
(Reginensi et al., 2011). Despite these variabilities, in general
epithelial Sox9 expression has been shown to promote progenitor
cell expansion and extracellular matrix (ECM) deposition (Chang
et al., 2013; Rockich et al., 2013; Chen et al., 2014). qPCR has
shown that Sox9 is expressed in developing salivary glands, with a
peak of expression at E15.5 (Lombaert and Hoffman, 2010). The
role of Sox9 in salivary glands, however, has not been assessed.
Here, we investigated the importance of Sox9 in salivary gland
development using the Sox9flox/flox; K14-Cre+ (Sox9CKO) mouse line,
in which Sox9 is ablated in epithelial tissues from the initiation stage
of salivary gland development. We find that Sox9 is highly expressed
in the distal epithelial progenitors where it is required for their
specification as a distal epithelial population and for subsequent
branching morphogenesis. Sox9 expression is maintained by Fgf10
signalling by a process that requires active Erk signalling.
RESULTS
Sox9 is restricted to the distal epithelial compartment from
the bud stage of development and is maintained in this
region throughout development
As a first approach to understanding the function of Sox9, we traced
its protein distribution during SMG development. During all stages,
Sox9, as expected for a transcription factor, was detected in the
nucleus and was absent from the epithelium of Sox9CKO glands,
indicating the high specificity of this antibody for Sox9 (Fig. 1;
Fig. S1B). At gland initiation (E11.0-11.5), all the epithelial cells of
the placode and the early invaginating bud were Sox9+ (Fig. 1A,B).
However, at the bud stage (E12.5), high levels of Sox9 expression
were only observed distally at the tip of the buds, with much lower
expression proximally next to the oral surface (Fig. 1C). This pattern
Fig. 1. Sox9 is expressed throughout the development of the submandibular gland. (A-F) Sox9 immunofluorescence (red) at the placode [E11.0 (A), E11.5 (B)],
initial bud [E12.5 (C)], pseudoglandular [E13.5 (D)], canalicular [E15.5 (E)] and adult (F) stages. DNA is shown in blue (DAPI), F-actin in yellow and Mist1 in green.
Dotted lines in A-D delineate the salivary gland epithelium. Insets in F showmagnifications of an acinus stained for Mist1 (green) and Sox9 (red). Arrowheads point to
Sox9-positive cells within the striated duct. G, ganglion; MC, Meckel’s cartilage; SL, sublingual gland; SMG, submandibular gland. Scale bars: 100 μm.
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of epithelial Sox9 expression, with higher levels at the distal tips,
was maintained throughout branching morphogenesis at E13.5 and
E15.5 (Fig. 1D,E). As lumens started to form in the more distal ducts
(as indicated by F-actin staining), Sox9 expression turned off (Fig. 1E).
Interestingly, in the adult when differentiation had fully occurred,
Sox9+ cells were still predominantly located in more distal structures,
with large numbers of positive acinar cells, as shown by co-expression
of Sox9 and Mist1 (Fig. 1F, insets). All Mist1+ cells were also Sox9+,
indicating an important link between these two transcription factors in
adult glands. Expression of Sox9 was also observed in the small
distally located intercalated ducts (Fig. 1F, yellow outline), whereas
fewer cells that stained less intensely were found in the bigger more
proximal ducts (Fig. 1F, arrowheads). Interestingly, the intensity of
Sox9 appeared to be lower in the acinar compartments than in the
intercalated ducts in the adult (Fig. 1F), suggesting a change in role in
fully differentiated glands. The PG (Fig. 2A-C) and SL (Fig. 2D-F)
glands displayed a similar pattern of Sox9 expression compared with
the SMG, suggesting that Sox9 plays a similar developmental role in
all of the three major salivary glands (Fig. 2).
Sox9+ epithelial cells are progenitors of the entire salivary
gland epithelium
Our protein localisation analysis revealed early Sox9 expression in
the placode epithelium. To investigate whether these early Sox9+
epithelial cells act as progenitors, we traced their progeny using
Sox9-creERT2 mice crossed with Rosa-tdTomato mice. After
tamoxifen administration at E10.5, the entire epithelium of the
E14.5 submandibular gland was labelled in red including all the
ductal and acinar structures (Fig. 3). In agreement with the early
Sox9 expression in the ganglia (Fig. 1C), label was also detected in
the ganglia cells found in close association with the submandibular
gland epithelium (Fig. 3C). Earlier tamoxifen administration
labelled the mesenchyme (date not shown) in agreement with
Sox9 expression in the neural crest cells that form the salivary gland
mesenchyme (Zhao et al., 1997).
Sox9 is required for the formation of distal epithelial
progenitors and for branching morphogenesis
To assess the role of Sox9 during salivary gland development, we
deleted Sox9 flox alleles in the oral epithelium using K14-Cre. The
K14 promoter induces Cre recombination in almost all epithelial
cells of the salivary gland from the initiation stage (Fig. S1A,B).
Immunofluorescence for Sox9 confirmed almost complete loss of
Sox9 in the salivary gland epithelium, although a very small number
of cells remained positive for Sox9, both at the placode (Fig. S1A,B)
and later at the bud stage (Fig. S1C,D). As expected, Sox9 was still
expressed in the surrounding mesenchyme, including Meckel’s
cartilage and the ganglia (Fig. S1B,D).
Although the initial thickening was normal, the bud was smaller
at E12.5 (Fig. S1B,D). This defect was more marked as the gland
continued to develop with Sox9CKO SMGs failing to branch
(Fig. 4A-C). Development of the submandibular and sublingual
glands arrested at the bud stage at time points when control glands
had undergone extensive branching (Fig. 4D,E). A delay in
branching was also evident in the heterozygous Sox9CHET mice
(Sox9flox/+; K14-Cre+) (Fig. 4B). The mesenchymal capsule that
develops around the epithelial tissue still formed in the Sox9CKO
mutants (Fig. 4D,E), however, as has been observed in Fgf10
mutant mice (Wells et al., 2013). Similar to the SMG and SL, the PG
was undetectable by E15.5 (Fig. 5) suggesting that Sox9 is required
for the formation of all three major salivary glands.
As branching morphogenesis is a process that involves cleft
formation and epithelial bud outgrowth through proliferation
(Harunaga et al., 2011), we assessed cleft formation by
morphological observation and laminin deposition (Fig. 4F;
Fig. S2) and proliferation by detecting bromodeoxyuridine (BrdU)
Fig. 2. Sox9 expression in the parotid and sublingual gland is similar to the submandibular. (A-F) Sox9 immunofluorescence (red) in the parotid (A-C) and
sublingual (D-F) glands at the bud stage (A,D) and at E14.5 (B,E) and E18.5 (C,F). Dotted white lines in D and E outline the sublingual glands. The white dotted
line in Foutlines an acinus and the yellowa duct. Arrow points to Sox9+ cells in the acinus and the arrowhead points to Sox9+ cells in the duct. DNA is shown in blue
(DAPI). Scale bars: 250 μm (A-C,E,F); 50 μm (D).
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incorporation (Fig. 4G-I). Although some degree of variability was
observed, approximately two-thirds of the Sox9CKO SMGs displayed
no signs of cleft formation, i.e. no ingression of laminin into the bud
(P<0.0001) (Fig. 4F; Fig. S2C) in contrast to controls, in which clefts
were observed in every case (Fig. 4F; Fig. S2A). In the Sox9CKO
SMGs in which a cleft formed, only a single cleft was observed,
whereas in the wild type two or more clefts were evident (Fig. S2). In
the lung, Sox9 ablation has been reported to cause aberrant laminin
deposition on the basal surface of the epithelium. However, in our
mutant salivary glands close examination of laminin in epithelial cells
revealed no obvious deposition on the basal surface compared with
controls (Fig. S2A′-C′), suggesting key differences between the lung
and salivary glands.
When proliferation was assessed, the ratio of cells that
incorporated BrdU as a proportion of the total number of cells in
the epithelium was reduced by approximately 25% in the Sox9CKO
SMGs compared with the control glands at the bud stage (P<0.05)
(Fig. 4G-I). The total number of epithelial cells was also reduced, by
approximately 50%, in the Sox9CKO SMGs compared with that of
controls at this stage (P<0.05) (Fig. 4L).
Having established that proliferation levels were significantly
reduced in the mutant, we then investigated cell death in the glands.
Apart from a few activated caspase 3+ cells at the site of ductal
formation in both control and mutant glands (Fig. 4J,K, arrowheads)
(Teshima et al., 2016b), no aberrant activation was detected in the
distal compartment, suggesting that loss of Sox9 does not lead to
death of the epithelial cells of the gland.
During branching morphogenesis (E13.5), epithelial progenitors
express different markers depending on their location along the
distal-proximal axis of the developing salivary gland. These distinct
populations contribute to the formation of different epithelial
structures (Matsumoto et al., 2016). Given that Sox9 is differentially
expressed from E12.5 onwards, we assessed the expression of
proximal (K5) and distal (Sox10,Myb) markers before the initiation
of branching morphogenesis, and found that the epithelial cells
could also be divided into two different populations at the bud stage,
with proximal cells located at the stalk expressing K5 (Fig. 6A) and
distal cells located at the tip of the endbud expressing Sox10 and
cMyb (Fig. 6D,F). The early specification of the initial bud into
distinct identities can be highlighted by dissecting the gland into
distal and proximal compartments. The distal endbud goes on to
branch in isolation, whereas the proximal stalk region fails to branch
and has more limited growth (Fig. S3A-E). These data suggest that
branching can initiate and progress independently of the proximal
epithelium.
To understand the role of Sox9 in distal cell fate, we investigated
the expression of Sox10 and Myb in Sox9CKO SMGs. Sox10 has
been shown to be positively regulated by Sox9 in the lacrimal glands
(Chen et al., 2014), whereas Myb has been shown to inhibit acinar
differentiation in SMGs (Matsumoto et al., 2016). Both Sox10 and
Myb were at low or undetectable levels in the Sox9CKO SMGs
(Fig. 6D-G) indicating loss of this progenitor population in the
absence of Sox9. To examine the identity of the epithelial
progenitors in the Sox9CKO SMGs, we investigated the expression
of the proximal marker K5 (Fig. 6A,B). When the total number of
cells was compared, the number of cells with a proximal identity
remained the same, but the number of K5− cells dramatically
dropped (Fig. 6C). This suggests that, contrary to the distal
progenitors, the proximal progenitors do not require Sox9
expression for their formation. To follow the proximal precursors
at a later stage we then investigated the expression of another
proximal marker, Sox2, at E13.5. Sox2 is normally expressed in the
proximal epithelial progenitors in the ductal region of E13.5 control
SMGs (Fig. 6H, arrow) (Lombaert et al., 2011). However,
expression in the absence of Sox9 was found throughout the
epithelium including the tip of the truncated Sox9CKO endbud
(Fig. 6I, arrowhead) suggesting that normal differentiation can
proceed in the absence of Sox9 in the remaining proximal
progenitors. Altogether, these data illustrate the differential
requirement of Sox9 for the formation of the distal progenitors as
opposed to the proximal progenitors.
Conserved dependence of type II collagen on Sox9
expression in salivary gland epithelium
In the mesenchyme, Sox9 is part of a hierarchy of genes that control
cartilage development (Bell et al., 1997). Some aspects of this
pathway also appear to be conserved in epithelial tissues, for
example with type II collagen being expressed in lung and lacrimal
gland epithelium (Rockich et al., 2013; Chen et al., 2014). We
therefore aimed to test whether type II collagen was also expressed
in salivary gland epithelium. Col2a1 was observed in the salivary
gland epithelium from E11.5, overlapping with Sox9 expression
(Fig. 7A, compare with Fig. 1B). As with Sox9, Col2a1 was later
restricted to the distal precursors (Fig. 7B). To test whether Col2a1
expression was dependent on Sox9, we assessed expression in our
conditional mutants (Fig. 7C,D). In the absence of Sox9, Col2a1
expression was lost in the gland, suggesting a conserved relationship
between these genes in both mesenchyme and epithelium (Fig. 7D).
To investigate whether the reduction of Col2a1 expression could
contribute to the branching defect observed in the Sox9CKO mice,
submandibular glands were treated ex vivo with collagenase for 2
days (Fig. 7E-H). Collagenase treatment did not increase apoptosis
in the epithelium, indicating no or low cytotoxic effects at this
Fig. 3. Sox9-positive cells are progenitors of the entire submandibular
gland epithelium. (A) Experimental strategy used to follow the progeny of
Sox9-expressing cells with the Sox9-creERT2; R26-tdTomato line. Tamoxifen
(TA) was given at E10.5 and embryos were collected at E14.5. (B-D) Tomato-
labelled cells (red) were detected in the whole submandibular gland at E14.5,
(B) in the acini (C) and in the duct (D). G, ganglion. Scale bars: 100 μm.
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concentration (Fig. 7E,F). However, in agreement with previous
observations from later stages (Nakanishi et al., 1986), collagenase
treatment resulted in a reduction in branch formation (Fig. 7G-I).
Thus, disruption of type II collagen in Sox9CKO salivary glands
might contribute to the defect in epithelial branching
morphogenesis.
Fig. 4. Sox9 is required for branching
morphogenesis. (A-C) Sox9
immunofluorescence (red) in control (A),
Sox9CHET (B) and Sox9CKO (C) at the
pseudoglandular stage (E13.5).
(D,E) Submandibular and sublingual
glands dissected from control (D) and
Sox9CKO (E) mice at E15.5.
(F) Quantification of cleft formation in the
control and Sox9CKO submandibular
glands at the pseudoglandular stage
(E13.5). ‘n’ equals the number of
submandibular glands. ***P<0.0001.
(G,H) BrdU immunofluorescence
(green) in control (G) and Sox9CKO
(H) submandibular glands at the bud
stage (E12.5). (I) Quantification of the
percentage of epithelial BrdU+ cells in
the control and Sox9CKO submandibular
glands at the bud stage (E12.5).
(J,K) Cleaved caspase 3
immunofluorescence (red) in control and
Sox9CKO submandibular glands at the
bud stage (E12.5). Arrowheads indicate
apoptotic cells at the stalk region.
(L) Quantification of epithelial cell
number in control and Sox9CKO
submandibular glands at the bud stage
(E12.5). Dotted lines in A-E,G,H,J,K
delineate the salivary gland epithelium.
Error bars in I and L represent s.e.m.;
*P<0.05. DNA is shown in blue (DAPI)
for A-C and G,H,J,K. SL, sublingual
gland; SMG, submandibular gland.
Scale bars: 200 μm (A-C); 500 μm
(D,E); 100 μm (G,H,J,K).
Fig. 5. Sox9 is required for parotid
gland development. (A-C) Sox9
immunofluorescence (red) in control
(A), Sox9CHET (B) and Sox9CKO (C)
parotid glands at E15.5. Arrowheads
indicate the position of the parotid
gland. DNA is shown in blue (DAPI).
Scale bar: 250 μm (A-C).
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Fgf10 maintains Sox9 expression through the Erk pathway
during SMG development
As Fgf signalling positively regulates Sox9 in other developing
branching organs (Seymour et al., 2012; Chang et al., 2013; Chen
et al., 2014), we hypothesised that Fgf10 might play a similar role in
the SMGs. In keeping with this, qPCR analysis has previously
shown upregulation of Sox9 after addition of Fgf7 or Fgf10 to wild-
type epithelial rudiments of SMG at the pseudoglandular stage
(Lombaert and Hoffman, 2010). We first examined the expression
of Fgf10 and Sox9 at the SMG initiation stage by in situ
hybridisation (Fig. 8A-D). As previously described, Fgf10 was
expressed in the mesenchyme surrounding the site of placode
formation (Fig. 8A,C) (Wells et al., 2013) whereas Sox9, as we have
shown, was specifically expressed at the site of the epithelial
thickening (Fig. 8B,D). Given the similar temporal and spatial
localisation of Fgf10 and Sox9, we were interested to see whether
this pattern correlates with a positive regulation. Thus, we examined
the expression of Sox9 in Fgf10 null mice (Fig. 8E,H). Fgf10 null
mice fail to develop a bud and their development is arrested at the
placode stage (Jaskoll et al., 2005). Sox9 was highly expressed in
the bud of the Fgf10+/+ SMGs but it was severely reduced in the
developmentally arrested placodes of the E12.5 Fgf10 null SMGs.
However, the mesenchymal expression of Sox9 in Meckel’s
cartilage and in the ganglion remained at the same levels (Fig. 8E,
H), suggesting Sox9 in these tissues is not regulated by Fgf10. In
addition, in keeping with the close relationship between Sox9 and
type II collagen, expression of Col2a1 in the gland tissue was
severely reduced at E12.5, with no effect on Col2a1 expression in
the adjacent Meckel’s cartilage (Fig. 8F,I). Loss of Sox9 in the
epithelium correlated with a reduction in the expression of Spry1, a
readout of Erk signalling, suggesting that activation of Sox9 by
Fgf10 acts through the Erk pathway during these initial stages of
SMG development (Fig. 8G,J).
To study this positive regulation of Sox9 by Fgf10 further, we
moved to an explant culture system. Mandibles were sliced frontally
and slices with SMGs were cultured for 24 h (Fig. 9). In control
cultures, the salivary gland tissue developed from a thickening to a
bud and exhibited high levels of Sox9 (Fig. 9A-C). In contrast,
slices cultured with SU5402, an inhibitor of the Fgf receptor
signalling pathway, failed to develop a fully formed bud and Sox9
levels were undetectable (Fig. 9D-F), mimicking the Fgf10
knockout phenotype. In contrast, Sox9 levels were maintained at
high levels in the cultures in the absence of the inhibitor (Fig. 9C).
Fgf receptors signal through several transduction pathways the
most common of which is the RAS-Erk pathway (Thisse and Thisse,
2005). To investigate which pathway controls Sox9 expression
Fig. 6. Sox9 is required for the specification of distal epithelial progenitors. (A-B′) Immunofluorescence for cytokeratin 5 (K5) (red) in control (A,A′) andSox9CKO
(B,B′) submandibular glands at the bud stage (E12.5). Yellow area in A′,B′ represents the K5− distal epithelial cells. (C) Total number of K5+ and K5− epithelial
cells in control and Sox9CKO submandibular glands at the bud stage (E12.5). *P<0.01; ns, not significant. Error bars represent s.e.m. (D,E) Immunofluorescence for
Sox10 (green) in control (D) and Sox9CKO (E) submandibular glands at the bud stage (E12.5). (F,G) In situ hybridisation for Myb in control (F) and Sox9CKO
(G) submandibular glands at the bud stage (E12.5). (H,I) Immunofluorescence for Sox2 in control (H) and Sox9CKO (I) submandibular glands at the pseudoglandular
stage (E13.5). Dotted lines (A-B’,D-I) delineate the salivary gland epithelium. Arrow and arrowhead indicate the proximal and distal progenitors, respectively. DNA is
shown in blue (DAPI) in A,B,D,E,H,I. G, ganglion; SL, sublingual gland; SMG, submandibular gland. Scale bars: 100 μm (A-B’,H,I); 50 μm (D,E); 500 μm (F,G).
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downstream of Fgf receptors, we inhibited the Erk pathway using
the MAPK inhibitor U0126. Mandible slices were treated at E11.0
for 1 day with U0126 and DMSO-treated cultures were used as a
control (Fig. 9G-I). Similar to the SU5402 treatment, the epithelium
of the U0126-treated explants failed to form a fully developed bud
(Fig. 9H) and to maintain Sox9 expression (Fig. 9I) suggesting that
Fgf receptor signalling positively regulates Sox9 through the Erk
pathway.
As Fgf10 is required to maintain Sox9, we went on to
investigate whether exogenous Fgf10 treatment could restore
Sox9 expression in Fgf10 null SMG epithelium (Fig. 9J-O). As
an Fgf10 source we used heparin-coated beads treated with Fgf10
to provide a localised supply of the protein (Fig. 9M,N); bovine
serum albumin (BSA)-treated beads were used as a control
(Fig. 9J,K). Beads were placed on E12.5 Fgf10 null mandible
slices in culture and the expression of Sox9 was assessed
(Fig. 9L,O). The level of Sox9 expression was rescued in the
Fgf10-treated slices compared with controls (Fig. 9L,O), further
supporting the suggestion that Sox9 is positively regulated by
Fgf10 in salivary glands.
Fig. 7. Type II collagen (Col2a1) is expressed in the distal progenitors and acts downstream of Sox9 possibly by contributing to branching. (A,B) In situ
hybridisation forCol2a1at the placode (A) and bud stage (B). (C,D) In situ hybridisation forCol2a1at the bud stage (E12.5) in control (C) andSox9CKO (D) submandibular
glands. (E,F) Immunofluorescence for cleaved caspase 3 (red) in control (E) and collagenase-treated (F) submandibular gland explants. DNA is shown in blue (DAPI).
(G,H) Brightfield images of control (G) and collagenase-treated (H) submandibular gland explants. (I) Spooner ratio of the number of buds produced in the control and
collagenase-treated submandibular gland explants. *P<0.05. Dotted lines (A-H) delineate the salivary gland epithelium. Error bars represent s.e.m. DIST, distal; MC,
Meckel’s cartilage; PROX, proximal; SL, sublingual gland; SMG, submandibular gland. Scale bars: 250 μm (A); 50 μm (B); 100 μm (C-F); 500 μm (G,H).
2300











Sox9 ablation does not lead to downregulation of Etv5
In the lacrimal glands, pancreas and kidney, Sox9 is involved in a
positive-feedback loop with Fgf10 for further upregulation of Fgf
signalling (Chen et al., 2014; Seymour et al., 2012; Reginensi et al.,
2011), with Etv5 expression, a downstream target of the Fgf receptor
pathway, reduced in the Sox9 mutant. To test whether Sox9 plays a
similar role in salivary glands, we performed in situ hybridisation
for Etv5 (Fig. S4A,B) and also for Fgf10 (Fig. S4C,D) on Sox9
mutant glands. In contrast to the development of other branching
organs, no detectable difference was found between the mutants and
control for both Etv5 (Fig. S4A,B) and Fgf10 (Fig. S4C,D),
indicating that Sox9 does not act in a positive-feedback loop with
Fgf signalling in salivary glands. Salivary glands, therefore, appear
to have distinct differences in Fgf signalling compared with other
branching organs.
DISCUSSION
Sox9 is a transcription factor involved in the development of many
branching organs including pancreas, lacrimal glands, lungs and
kidneys. Although salivary glands are also branching organs, the
role of Sox9 during their development has not previously been
addressed. Here, we have shown that Sox9 is expressed throughout
Fig. 8. Fgf10 maintains Sox9 expression during the initial stages of salivary gland development. (A-D) In situ hybridisation for Fgf10 (A,C) and
Sox9 (B,D) on E11.0 mandibles (A,B) and frontal mandibular slices (C,D). Arrowheads indicate the site of expression in submandibular glands.
(E,H) Immunofluorescence for Sox9 in Fgf10+/+ and Fgf10−/− submandibular glands at E12.5. (F-J) In situ hybridisation for Col2a1 (F,I) and Spry1 (G,J) in
Fgf10+/+ (F,G) and Fgf10−/− (I,J) submandibular glands. Dotted lines delineate the tongue (A,B), the placode of the salivary glands (C,G,J) or the salivary gland
epithelium (E,F,H,I). Boxes (G,J) indicate the placode of the developing submandibular glands, asmagnified in insets. G, ganglion; MC,Meckel’s cartilage; SL,
sublingual gland; SMG, submandibular gland. Scale bars: 500 μm (A-D,G,J); 50 μm (E,H); 100 μm (F,I).
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the development of salivary glands from the salivary gland initiation
stage to the fully differentiated adult salivary gland. These early
Sox9+ epithelial cells are the progenitors of the entire salivary gland
epithelium. In order to assess Sox9 function, we used the K14
promoter to specifically ablate epithelial Sox9 expression from the
developing salivary glands. We demonstrated that Sox9 is required
for salivary gland morphogenesis by promoting the formation of the
distal epithelial progenitor population, the presence of which is
essential for subsequent branching. Abnormal branching and gland
formation was observed in all three major Sox9CKO glands, the
submandibular, sublingual and parotid. Sox9 is therefore required
for the development of all three major salivary glands, irrespective
of whether the gland is mucous or serous.
Sox9 is required for the formation of distal epithelial
progenitors and branching morphogenesis
Branching morphogenesis is a dynamic process that involves
repetitive rounds of epithelial budding, clefting and epithelial
outgrowth. This requires the coordination of different mechanisms,
which includes ECM deposition, cell migration and epithelial
proliferation (Harunaga et al., 2011). We have shown here that the
mechanism of branch formation can be driven by the distal part of
the epithelium alone (endbud) without the need of the proximal
(stalk) epithelium. The branching defect observed in the Sox9CKO
salivary glands is related to a failure in the specification of the distal
epithelial population. Despite subtle differences in clefting, which
could be attributed to differences in the number of Sox9+ cells that
remained after recombination, all the Sox9CKO SMGs examined
were arrested at the bud stage with an absence of the distal markers
Myb and Sox10. Interestingly, this phenotype is specific to the
salivary glands as Sox9 ablation in other branching organs leads
either to complete agenesis (lacrimal glands) (Chen et al., 2014) or
to reduced branching (lungs, pancreas) (Chang et al., 2013; Rockich
et al., 2013; Seymour et al., 2007), suggesting that the requirement
for Sox9 during development is specific to the branching organ.
Despite the tissue-specific requirement for Sox9, we have shown
that in salivary glands Sox9 can regulate a similar subset of genes
important for branching. This includes Sox10 and Col2a1, which
are also downregulated in the Sox9CKO lacrimal glands and lungs
(Chen et al., 2014; Rockich et al., 2013).
Fig. 9. Fgf receptor signalling
maintains Sox9 expression through the
Erk pathway. (A,B,D,E,G,H) Brightfield
images of wild-type mandibular slice
cultures treated with DMSO (A,B), the
Fgf receptor inhibitor SU5402 (D,E)
or the Erk inhibitor U0126 (G,H).
(C,F,I) Immunofluorescence for Sox9 (red)
and F-actin (green) in DMSO- (C),
SU5402- (F) and U0126- (I) treated
mandibular slice cultures.
(J,K,M,N) Brightfield images of Fgf10−/−
mandibular slice cultures treated with
BSA-treated beads (blue) (J,K) or Fgf10-
treated beads (pale yellow) (M,N).
(L,O) Immunofluorescence for Sox9 in
Fgf10−/− mandibles treated with BSA-
treated beads (L) or Fgf10-treated beads
(O). DNA is shown in blue (DAPI) in C,F,I,
L,O. Boxes indicate the placode of the
developing submandibular glands. Insets
show higher magnifications of the boxed
areas. Dotted lines outline the epithelium
of the placodes. Arrowheads indicate the
submandibular glands. Mc, Meckel’s
cartilage. Scale bars: 200 μm (C,F,I,L,O);
500 µm (A,B,D,E,G,H,J,K,M,N).
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Loss of type II collagen expression could contribute to the arrest
in branch formation observed in the Sox9CKO SMGs as reduction of
collagens with collagenase treatment in culture led to a loss of
branching. In keeping with this, inhibition of collagenases has been
shown to stimulate branching morphogenesis (Nakanishi et al.,
1986). Our paper therefore provides a link between Sox9, distal
progenitor formation and branching morphogenesis.
Fgf10 signalling positively regulates Sox9 expression
through the Erk pathway
Sox9 has a distinct proximo-distal expression pattern from early bud
stages; however, at the placode stage it is expressed throughout the
epithelium. This change in expression might be driven by the
changing pattern of Fgf10 expression, which becomes more focused
around the distal part of the gland as it develops. In the Fgf10 null
salivary gland, expression of Sox9 was lost at the late placode stage.
In culture, Fgf7 has been shown to be able to strongly increase the
expression levels of Sox9 (Lombaert and Hoffman, 2010), but in vivo
Fgf10 appears to be the dominant Fgf for Sox9 expression. TheFgf10
null, however, had amore severe phenotype than the conditional Sox9
mutant with an arrest at the placode stage. Although some of the
phenotype in the Fgf10 null might be generated by loss of Sox9, other
genes are also likely to be affected. For example, inhibition of Fgf
receptor signalling influences the activity of Wnt and Bmp signalling
(Patel et al., 2011; Knosp et al., 2015; Hoffman et al., 2002).
Fgf10 heterozygous mice are viable but have been shown to have
smaller salivary glands (May et al., 2015). Interestingly, at E13.5 the
Sox9CHET glands were smaller than the control littermates and had
reduced numbers of branches, it would therefore be interesting to study
whether the glands stay small or are rescued later in development.
In our culture experiments, we were able to rescue the expression
of Sox9 in Fgf10 null glands by addition of Fgf10 protein, implying
that Sox9 is regulated by Fgf10 acting through the Erk pathway.
Although loss of Sox9 has been associated with a subsequent loss of
Fgf signalling in many branching organs, we saw no such reduction
in the salivary glands (Chen et al., 2014; Seymour et al., 2012;
Reginensi et al., 2011). This implies that a positive-feedback loop
between Sox9 and Fgf10 is not a universal part of branching
morphogenesis. In the lungs, although Etv5 is downregulated,
Fgf10 itself appeared to be upregulated (Chang et al., 2013). Again,
we found no change in Fgf10, confirming that Sox9 does not appear
to be able to influence Fgf signalling in salivary glands.
Interestingly, although inhibition of Fgf10 and Erk signalling led
to a loss of Sox9 in the gland epithelium, no change in Sox9
expression was observed in the neighbouring developing cartilage,
showing that although some aspects of the cartilage pathway are
preserved in the glands (Sox9 induction of type II collagen), the
specific involvement of Erk signalling is unique to the glands.
The current results lead us to introduce a working model in which
mesenchymal Fgf10 via the Fgf and Erk pathway, activates Sox9
expression in the epithelium. Sox9 promotes the formation and
proliferation of distal epithelial progenitors, and in the absence of
this population the gland is unable to undergo branching
morphogenesis (Fig. 10). These results provide insights into the
mechanisms of progenitor cell function underlying normal salivary
gland morphogenesis and could prove useful in designing methods
for regeneration of branching organs.
MATERIALS AND METHODS
Mouse strains and lineage tracing
Sox9 floxed, Fgf10 null and K14-cre, Sox9-creERT2 and Rosa-tdTomato
mice have been previously described (Kist et al., 2002; Min et al., 1998;
Vasioukhin et al., 1999; Soeda et al., 2010;Madisen et al., 2010). For the lineage-
tracing experiments, 75 mg tamoxifen/kg body weight was administered
interperitoneally into E10.5 pregnant mice. The day of the vaginal plug was
estimated as day 0.5 of embryonic development. All procedures and culling
methods were compliant with UK Home Office regulations and with the
approval of the King’s College London Biological Safety committee.
Histology, immunofluorescence and in situ hybridisation
Tissue was embedded in paraffin as previously described (May et al.,
2015). Immunofluorescence was performed either on paraffin-embedded
tissue or on whole-mount dissected embryonic salivary glands and
explant cultures (Gaete et al., 2015). Primary antibodies and dilutions
were used as follows: anti-Sox9 1:300 (AB5535, Millipore); anti-BrdU
1:500 (ab6326, Abcam), anti-Sox2 1:200 (#2748, Cell Signaling
Technology); anti-Mist1 1:50 (sc-98771, Santa Cruz Biotechnology),
for which signal was amplified with the TSA kit (PerkinElmer); anti-
laminin 1:300 (L9393, Sigma); anti-K5 1:300 (119-13621, Cambridge
Bioscience); anti-Sox10 1:100 (sc-365692, Santa Cruz Biotechnology)
using the TSA kit; anti-cleaved caspase 3 1:200 (#9661, Cell Signaling
Technology). In situ hybridisation was performed as previously
described (Gaete et al., 2015). Plasmids for probe generation have
been described previously: Spry1 (Minowada et al., 1999), Fgf10
(Bellusci et al., 1997), Myb (Matalová et al., 2011), Etv5 (Hippenmeyer
et al., 2002) and Col2a1 (Ng et al., 1997).
Proliferation and cell quantification analysis
For proliferation analysis, 20 mg BrdU per kg of pregnant mouse were
injected intraperitoneally 30 min before harvesting. Tissue was then
embedded in paraffin and processed for immunofluorescence. For BrdU
immunofluorescence, samples were treated for 30 min with 2 M HCl at
40°C prior to the addition of primary antibody. The mean cell proliferation
index (BrdU+/epithelial cells) for each gland was determined by analysing
three different sections. For the cell quantification of epithelial progenitors,
the section passing through the middle of the gland was quantified. Cells
were quantified manually using the cell counter plug-in of Fiji/ImageJ
(Schindelin et al., 2012). Results were plotted and statistically analysed
using GraphPad Prism software. Data were analysed using a one-way
ANOVA test apart from the cleft formation graph, which was analysed using
the Chi-squared test. For all the quantification experiments, at least three
independent biological replicates were used. Significance was taken as
P<0.05 (*), P<0.01 (**) or P<0.001 (***).
Fig. 10. Model of Fgf10 and Sox9 function during salivary gland budding
and branching morphogenesis. Sox9 is required for branching initiation by
promoting the formation of distal epithelial progenitors and their proliferation.
Mesenchymal Fgf10 maintains epithelial Sox9 expression during salivary
gland development by activating the Erk pathway through Fgfr2.
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Mandibular slice cultures were performed as previously described (Wells
et al., 2013; Li et al., 2016). For the bead experiment, two types of beads were
used to help distinguish between the control and treated conditions. For the
Fgf10-treated explants, heparin beads (Sigma, 100-200 mesh) were incubated
overnight at 4°Cwith 100 μg/ml Fgf10 (R&DSystems). For the control, Affi-
Gel blue beads (Bio-Rad,153-7302) were treated with 0.5% BSA. For
inhibiting Fgf receptor signalling or the Erk pathway, explant cultures were
treated with 2.5 μM SU5402 (Merck) or 5 μM U0126 (Cell Signaling
Technology), respectively, made up in DMSO. Control cultures were treated
with equivalent concentrations of DMSO (0.25%DMSO for the SU5402 and
0.5%DMSOfor theU0126 experiment). For the collagenase treatment,whole
E12.5 submandibular glands were dissected and treated for 2 days with 1 μg/
ml collagenase, Type II (Thermo Fisher Scientific) and HBSS-treated glands
were used as a control. Spooner ratios were calculated as the number of buds at
the end of culture divided by the number of buds at the start of culture.
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